Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents
Dec 5 (Reuters) - Pfizer Inc PFE.N and its German partner BioNTech SE 22UAy.DE fired back on Monday at a patent lawsuit filed by Moderna Inc MRNA.O in Boston federal court over their rival COVID-19 vaccines, seeking a dismissal of the lawsuit and a court order that they did not infringe Moderna's patents. (Reporting by New York Newsroom; Editing by Mark Porter)
Recent news on CureVac NV
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Biontech Closes Acquisition Of CureVac
Brief: BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025
Brief: Curevac Reaffirms Its Expected Cash Runway Into 2028